STOCK TITAN

Oncolytics Biotech Inc Stock Price, News & Analysis

ONCY Nasdaq

Welcome to our dedicated page for Oncolytics Biotech news (Ticker: ONCY), a resource for investors and traders seeking the latest updates and insights on Oncolytics Biotech stock.

Oncolytics Biotech Inc (ONCY) is a clinical-stage biotech company advancing pelareorep, an innovative oncolytic virus immunotherapy targeting multiple cancer types. This dedicated news hub provides investors and researchers with centralized access to corporate developments and scientific progress updates.

Track critical updates including clinical trial results, regulatory milestones, and strategic partnerships. Our curated collection features press releases spanning Phase 2 breast cancer studies, pancreatic cancer research advancements, and manufacturing capacity expansions. Regular updates ensure timely awareness of key developments in HR+/HER2- metastatic breast cancer trials and other high-priority programs.

Discover verified information on pelareorep's mechanism of action, trial design specifics, and intellectual property developments. The resource eliminates the need by aggregating essential updates from randomized controlled studies to manufacturing quality initiatives. Bookmark this page for efficient monitoring of Oncolytics' progress in transforming cancer treatment through viral immunotherapy approaches.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.91%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.03%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.03%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.32%
Tags
conferences earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.61%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.45%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.13%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.99%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.89%
Tags
conferences

FAQ

What is the current stock price of Oncolytics Biotech (ONCY)?

The current stock price of Oncolytics Biotech (ONCY) is $0.51 as of May 6, 2025.

What is the market cap of Oncolytics Biotech (ONCY)?

The market cap of Oncolytics Biotech (ONCY) is approximately 49.4M.
Oncolytics Biotech Inc

Nasdaq:ONCY

ONCY Rankings

ONCY Stock Data

49.36M
82.87M
4.35%
1.62%
3.44%
Biotechnology
Healthcare
Link
Canada
Calgary